by Madaline Spencer | Oct 16, 2025
Jai Radhakrishnan, MD, Nephrologist and Professor at Columbia University Medical Center, discusses diagnosis and treatment of IgA nephropathy (IgAN). IgAN is an autoimmune kidney disorder characterized by the settling of IgA protein in the kidneys. In...
by Madaline Spencer | Oct 15, 2025
Giselle Saulnier Sholler, MD, Division Chief for Pediatric Hematology/Oncology at Penn State University and Founder of the Beat Childhood Cancer Research Consortium, discusses the organization’s work in neuroblastoma. Neuroblastoma is a rare cancer...
by Madaline Spencer | Oct 14, 2025
May Lee Tjoa, PhD, Senior Global Medical Affairs Leader: Nipocalimab and Maternal-Fetal Immunology at Johnson & Johnson, discusses data on hemolytic disease of the fetus and newborn (HDFN) from the 2025 ISUOG World Congress on Ultrasound in Obstetrics and...
by Madaline Spencer | Oct 13, 2025
Amit Mehta, MD, Medical Oncologist, discusses data that led to the approval of Wayrilz (rilzabrutinib) for adult patients with immune thrombocytopenia (ITP). ITP is a bleeding disorder characterized by low levels of platelets. It is an autoimmune...
by Madaline Spencer | Oct 10, 2025
Mike Flanagan, PhD, Chief Scientific Officer at Avidity Biosciences, discusses new data from the EXPLORE44 open-label extension of del-zota for treatment of patients with Duchenne muscular dystrophy (DMD) amenable to exon 44 skipping. DMD affects the...
